يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"Burke, PW"', وقت الاستعلام: 0.26s تنقيح النتائج
  1. 1
    Conference
    A phase 1B/2 study of the CD123-targeting antibody-drug conjugate pivekimab sunirine (IMGN632) in combination with venetoclax (VEN) and azacitidine (AZA) for patients with CD123-positive AML

    المؤلفون: Daver, NG, Montesinos, P, Aribi, A, Martinelli, G, Altman, J, Roboz, G, Wang, ES, Burke, PW, Jeyakumar, D, Walter, RB, DeAngelo, DJ, Erba, HP, Advani, A, Gastaud, L, Thomas, X, Todisco, E, Pemmaraju, N, Mendez, L, de la Fuente, A, Gaidano, G, Curti, A, Boissel, N, Recher, C, Schliemann, C, Vyas, P, Sloss, CM, Wang, J, Malcolm, KA, Zweidler‐McKay, PA, Sweet, KL

    Relation: https://doi.org/10.1097/01.hs9.0000845108.16448.06

    الاتاحة: https://doi.org/10.1097/01.hs9.0000845108.16448.06
    https://ora.ox.ac.uk/objects/uuid:7b0132d1-6bad-4736-8f00-38170a35ec34

    View record in BASE

    أضف إلى المفضلة
  2. 2
    Academic Journal
    AML-262 Pivekimab Sunirine (PVEK, IMGN632) triplet with azacitidine and venetoclax shows broad activity in adverse genetic subsets of relapsed/refractory acute myeloid leukemia and reduced infusion-related reactions

    المؤلفون: Daver, N, Montesinos, P, Aribi, A, Martinelli, G, Altman, JK, Wang, ES, Roboz, GJ, Burke, PW, Gaidano, G, Walter, RB, Thomas, X, Jeyakumar, D, DeAngelo, DJ, Erba, HP, Todisco, E, Begna, K, Advani, A, Gastaud, L, de la Fuente, A, Curti, A, Mendez, LM, Vyas, P, Boissel, N, Vey, N, Recher, C, Longval, T, Platzbecker, U, Kapp-Schwörer, S, Schliemann, C, Konopleva, M, Torres, L, Sallman, DA, Marcucci, G, Marconi, G, Kantarjian, H, Sloss, CM, Malcolm, KE, Zweidler-McKay, PA, Sweet, K

    Relation: https://ora.ox.ac.uk/objects/uuid:da6b2b1b-b2ea-48e0-90ff-24017317cd49; https://doi.org/10.1016/S2152-2650(22)01257-5

    الاتاحة: https://doi.org/10.1016/S2152-2650(22)01257-5
    https://ora.ox.ac.uk/objects/uuid:da6b2b1b-b2ea-48e0-90ff-24017317cd49

    View record in BASE

    أضف إلى المفضلة
  3. 3
    Academic Journal
    Pivekimab Sunirine (PVEK, IMGN632) Triplet With Azacitidine and Venetoclax Shows Broad Activity in Adverse Genetic Subsets of Relapsed/Refractory Acute Myeloid Leukemia and Reduced Infusion-Related Reactions

    المؤلفون: Daver, N, Montesinos, P, Aribi, A, Martinelli, G, Altman, JK, Wang, ES, Roboz, GJ, Burke, PW, Gaidano, G, Walter, RB, Thomas, X, Jeyakumar, D, DeAngelo, DJ, Erba, HP, Todisco, E, Begna, K, Advani, A, Gastaud, L, de la Fuente, A, Curti, A, Mendez, LM, Vyas, P, Boissel, N, Vey, N, Recher, C, Longval, T, Platzbecker, U, Kapp-Schworer, S, Schliemann, C, Konopleva, M, Torres, L, Sallman, DA, Marcucci, G, Marconi, G, Kantarjian, H, Sloss, CM, Malcolm, KE, Zweidler-McKay, PA, Sweet, K

    المساهمون: Daver, N, Montesinos, P, Aribi, A, Martinelli, G, Altman, Jk, Wang, E, Roboz, Gj, Burke, Pw, Gaidano, G, Walter, Rb, Thomas, X, Jeyakumar, D, Deangelo, Dj, Erba, Hp, Todisco, E, Begna, K, Advani, A, Gastaud, L, de la Fuente, A, Curti, A, Mendez, Lm, Vyas, P, Boissel, N, Vey, N, Recher, C, Longval, T, Platzbecker, U, Kapp-Schworer, S, Schliemann, C, Konopleva, M, Torres, L, Sallman, Da, Marcucci, G, Marconi, G, Kantarjian, H, Sloss, Cm, Malcolm, Ke, Zweidler-McKay, Pa, Sweet, K

    مصطلحات موضوعية: AML, ADC, combination therapy, pivekimab

    Relation: info:eu-repo/semantics/altIdentifier/wos/WOS:000897948100136; volume:22; firstpage:231; lastpage:232; numberofpages:2; journal:CLINICAL LYMPHOMA MYELOMA & LEUKEMIA; https://hdl.handle.net/11579/155013; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85138157209

    الاتاحة: https://hdl.handle.net/11579/155013
    https://doi.org/10.1016/S2152-2650(22)01257-5

    View record in BASE

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء